DISCOVERY OF A NOVEL AND POTENT CHOLESTEROL ABSORPTION INHIBITOR AS PROMISING ORALLY ACTIVE LIPID LOWERING DRUG

被引：0
|
作者：
Kanou, M. [1 ]
Nishiwaki, Y. [2 ]
Nakano, A. [2 ]
Yamanaka, Y. [2 ]
机构：
[1] Teijin Pharma Ltd, Pharmaceut Dev Res Labs, Tokyo, Japan
[2] Teijin Pharma Ltd, Pharmaceut Discovery Res Labs, Tokyo, Japan
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2010年 / 11卷 / 02期
关键词：
D O I：
10.1016/S1567-5688(10)70360-3
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
P293
引用
收藏
页码：79 / 79
页数：1
相关论文
共 50 条
  • [21] Discovery of PAT-1102, a Novel, Potent and Orally Active Histone Deacetylase Inhibitor with Antitumor Activity in Cancer Mouse Models
    Hiriyan, Jagadheshan
    Shivarudraiah, Prasad
    Gavara, Govindarajulu
    Annamalai, Pazhanimuthu
    Natesan, Selvakumar
    Sambasivam, Ganesh
    Sukumaran, Sunil K.
    ANTICANCER RESEARCH, 2015, 35 (01) : 229 - 237
  • [22] J-104,123, a novel and orally-active inhibitor of squalene synthase: Stereoselective synthesis and cholesterol lowering effects in dogs
    Iwasawa, Y
    Shibata, J
    Mitsuya, M
    Masaki, H
    Hayashi, M
    Kanno, T
    Sawasaki, Y
    Hisaka, A
    Kamei, T
    Tomimoto, K
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (04) : 463 - 466
  • [23] Discovery of a Pyrimidinedione Derivative as a Potent and Orally Bioavailable Axl Inhibitor
    Zhang, Hefeng
    Peng, Xia
    Dai, Yang
    Shao, Jingwei
    Ji, Yinchun
    Sun, Yiming
    Liu, Bo
    Cheng, Xu
    Ai, Jing
    Duan, Wenhu
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (07) : 3956 - 3975
  • [24] Lipid lowering activity of drugs affecting cholesterol absorption
    Norata, GD
    Catapano, AL
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2004, 14 (01) : 42 - 51
  • [25] A novel orally active inhibitor of HLE
    Varga, M
    Kapui, Z
    Bátori, S
    Nagy, LT
    Vasvári-Debreczy, L
    Mikus, E
    Urbán-Szabó, K
    Arányi, P
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2003, 38 (04) : 421 - 425
  • [26] Discovery of a potent, orally available tricyclic derivative as a novel BRD4 inhibitor for melanoma
    Horai, Yuhei
    Suda, Naoki
    Uchihashi, Shinsuke
    Katakuse, Mayako
    Shigeno, Tomomi
    Hirano, Takashige
    Takahara, Junichi
    Fujita, Tomoyuki
    Mukoyama, Yohei
    Haga, Yuji
    BIOORGANIC & MEDICINAL CHEMISTRY, 2023, 93
  • [27] Cholesterol absorption as a target for lipid-lowering therapy
    Cohen, DE
    FORMULARY, 2004, 39 : 3 - 7
  • [28] Discovery of WX486 as a novel, potent, selective, and orally bioavailable irreversible inhibitor of BTK
    Wu, Chengde
    Shen, Chunli
    Zhu, Yuchuan
    Hu, Guoping
    Lin, Jian
    Chen, Shuhui
    Xiao, Qiang
    Huang, Lu
    Chen, Hailiang
    Tu, Ronghua
    Xu, Yong
    Wang, Xuehai
    JOURNAL OF IMMUNOLOGY, 2016, 196
  • [29] Sar in the alkoxy lactone series:: The discovery of DFP, a potent and orally active COX-2 inhibitor
    Leblanc, Y
    Roy, P
    Boyce, S
    Brideau, C
    Chan, CC
    Charleson, S
    Gordon, R
    Grimm, E
    Guay, J
    Léger, S
    Li, CS
    Riendeau, D
    Visco, D
    Wang, Z
    Webb, J
    Xu, LJ
    Prasit, P
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (15) : 2207 - 2212
  • [30] Discovery and preclinical characterization of BMN 673, a highly potent and orally active PARP inhibitor as an anticancer agent
    Wang, Bing
    Chu, Daniel
    Shen, Yuqiao
    Feng, Ying
    Myers, Peter
    Post, Leonard
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
12345